tiprankstipranks
Trending News
More News >

EyePoint Pharmaceuticals Approves Share Increase at Annual Meeting

Story Highlights
  • EyePoint Pharmaceuticals held its 2025 Annual Meeting on June 18, approving a share increase.
  • Shareholders elected directors, approved compensation, and ratified Deloitte as auditor.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
EyePoint Pharmaceuticals Approves Share Increase at Annual Meeting

Don’t Miss TipRanks’ Half-Year Sale

EyePoint Pharmaceuticals ( (EYPT) ) has shared an update.

On June 18, 2025, EyePoint Pharmaceuticals held its Annual Meeting of Stockholders via webcast, where stockholders approved an amendment to increase the number of shares in the 2023 Long-Term Incentive Plan by 2,900,000 shares. Additionally, the meeting included the election of directors, approval of executive compensation, and ratification of Deloitte & Touche LLP as the independent auditor, reflecting strong shareholder engagement and strategic alignment with the company’s growth objectives.

The most recent analyst rating on (EYPT) stock is a Buy with a $30.00 price target. To see the full list of analyst forecasts on EyePoint Pharmaceuticals stock, see the EYPT Stock Forecast page.

Spark’s Take on EYPT Stock

According to Spark, TipRanks’ AI Analyst, EYPT is a Neutral.

EyePoint Pharmaceuticals’ stock score is primarily driven by strong technical indicators and promising clinical developments. However, financial performance issues, especially profitability and cash flow challenges, weigh down the score. The positive sentiment from the earnings call and bullish technical trends provide a balanced outlook, though continued financial improvements are essential for long-term growth.

To see Spark’s full report on EYPT stock, click here.

More about EyePoint Pharmaceuticals

EyePoint Pharmaceuticals, Inc. operates in the pharmaceutical industry, focusing on the development and commercialization of ophthalmic products. The company is known for its innovative drug delivery systems aimed at treating serious eye disorders.

Average Trading Volume: 830,659

Technical Sentiment Signal: Hold

Current Market Cap: $613.8M

Learn more about EYPT stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1